```html

Xeritis (Dry Eye) – A Complete Medical Guide

Overview

Xeritis—also known as dry eye disease (DED) or keratoconjunctivitis sicca—is a multifactorial disorder of the ocular surface characterized by insufficient tear production, excessive tear evaporation, or both. The result is a destabilized tear film that cannot adequately lubricate, nourish, or protect the cornea and conjunctiva.

Who it affects

• Women are 2‑3 times more likely than men to develop xeritis.
• Prevalence rises sharply after age 40; up to 30% of people over 50 have clinically significant dry eye.^1
• Contact‑lens wearers, people who spend many hours on digital screens, and those with certain autoimmune diseases (e.g., Sjögren’s syndrome, rheumatoid arthritis) are at higher risk.

Globally, dry eye affects an estimated 5‑30% of the adult population, making it one of the most common ocular surface conditions worldwide.^2

Symptoms

Symptoms can range from mild irritation to severe pain and visual disturbance. They may fluctuate throughout the day and worsen in windy, dry, or air‑conditioned environments.

• Foreign‑body sensation – feeling of grit or a “sand‑like” particle in the eye.
• Burning or stinging – often described as a mild to moderate ache.
• Itching – more common when inflammation is present.
• Redness – due to conjunctival hyperemia.
• Blurred vision – especially after prolonged visual tasks (reading, computer work). Vision typically clears after blinking.
• Excessive tearing – paradoxical reflex tearing that occurs when the ocular surface is irritated.
• Eye fatigue – a feeling of heaviness after reading or screen time.
• Sensitivity to light (photophobia).
• Sticky eyelids – especially upon waking.

Causes and Risk Factors

Primary Mechanisms

• Aqueous‑deficient dry eye – decreased production of the watery component of tears by the lacrimal glands (e.g., Sjögren’s syndrome, age‑related gland atrophy).
• Evaporative dry eye – increased tear loss due to Meibomian gland dysfunction, eyelid abnormalities, or environmental factors.

Common Risk Factors

• Age > 40 years.
• Female sex (especially post‑menopausal).
• Autoimmune disorders: Sjögren’s syndrome, rheumatoid arthritis, lupus, thyroid disease.
• Medications that reduce tear production: antihistamines, decongestants, antidepressants, anticholinergics, isotretinoin, beta‑blockers.
• Contact lens wear (especially extended‑wear lenses).
• High‑intensity visual tasks: computer use, smartphone, gaming (reduced blink rate).
• Environmental exposures: low humidity, wind, air‑conditioning, smoke.
• Ocular surgeries: LASIK, cataract extraction, ptosis repair.
• Refractive errors & uncorrected vision problems.

Diagnosis

Diagnosis is clinical but supported by several objective tests.

History & Physical Exam

• Detailed symptom questionnaire (e.g., Ocular Surface Disease Index – OSDI).
• Assessment of visual acuity, slit‑lamp examination, and eyelid margin evaluation.

Diagnostic Tests

• Schirmer I test – strips of filter paper placed under the lower eyelid to measure tear volume (≤5 mm/5 min suggests aqueous deficiency).
• Tear Break‑Up Time (TBUT) – fluorescein dye used to time how quickly the tear film destabilizes; <10 seconds is abnormal.
• Ocular surface staining – fluorescein, rose Bengal, or lissamine green highlight damaged epithelium.
• Meibomian gland evaluation – expression of gland secretions and infrared meibography to assess obstruction.
• Tear osmolarity – values >308 mOsm/L indicate hyperosmolarity, a hallmark of dry eye.
• Inflammatory marker testing – MMP‑9 point‑of‑care assay (e.g., InflammaDry).

In complex cases, referral to an ocular surface specialist or rheumatologist may be necessary to rule out systemic disease.

Treatment Options

Treatment follows a step‑wise approach, ranging from lifestyle modifications to prescription medications and procedural interventions.

1. Lifestyle & Environmental Modifications

• Follow the 20‑20‑20 rule during screen work (every 20 minutes, look at something 20 feet away for 20 seconds).
• Use a humidifier (30–40% relative humidity) in dry indoor environments.
• Wear wrap‑around sunglasses outdoors to reduce wind exposure.
• Stay hydrated; aim for ≥2 L of water daily.

2. Over‑the‑Counter (OTC) Options

• Artificial tears – preservative‑free drops (e.g., Refresh® Optive, Systane® Ultra). Use 4–6 times daily, increasing as needed.
• Lipid‑based lubricants – restore the oily layer (e.g., Refresh Lipid, Systane Complete).
• Warm compresses & lid hygiene – 5–10 minutes with a warm compress followed by gentle lid scrubs to improve Meibomian gland function.

3. Prescription Medications

• Cyclosporine A 0.05% ophthalmic emulsion (Restasis®) – reduces ocular surface inflammation; may take 4–6 weeks for effect.
• Lifitegrast 5% (Xiidra®) – blocks LFA‑1/ICAM‑1 interaction, decreasing inflammation; typical dose twice daily.
• Corticosteroid eye drops – short‑term use (e.g., loteprednol, fluorometholone) for acute flares, under close supervision.
• Topical antibiotics (e.g., azithromycin) for blepharitis‑related Meibomian gland dysfunction.

4. Procedural Interventions

• Punctal plugs – silicone or collagen plugs inserted into tear drainage openings to retain tears.
• Meibomian gland expression (MGE) – in‑office manual or thermal expression to clear obstructed glands.
• Intense pulsed light (IPL) therapy – reduces vascular inflammation and improves gland function.
• Thermal pulsation systems (e.g., LipiFlow®) – delivers heat and pressure to unblock glands.
• Autologous serum eye drops – for severe refractory cases; contain growth factors and vitamins similar to natural tears.
• Scleral contact lenses – vault over the cornea, creating a tear‑filled reservoir for chronic severe dry eye.

5. Systemic Therapy (selected cases)

• Oral omega‑3 fatty acid supplementation (1000 mg EPA/DHA twice daily) – modest benefit in inflammation reduction.^3
• Systemic immunomodulators (e.g., hydroxychloroquine) for underlying autoimmune disease, coordinated with a rheumatologist.

Living with Xeritis

Effective self‑care and regular follow‑up can dramatically improve quality of life.

• Daily regimen – schedule artificial‑tear drops at waking, mid‑day, and before bedtime.
• Blink exercises – consciously blink fully every 5 minutes during screen use.
• Eye protection – use protective goggles when exposed to wind, smoke, or chemical fumes.
• Nutrition – incorporate foods rich in omega‑3s (fatty fish, flaxseed, walnuts).
• Medication review – discuss with your physician any systemic drugs that may exacerbate dryness.
• Regular eye exams – at least once a year, or more often if symptoms change.

Prevention

While some risk factors (age, genetics) cannot be changed, many modifiable steps can lower the likelihood of developing xeritis or worsening existing disease.

• Maintain a balanced diet high in omega‑3 fatty acids.
• Stay hydrated throughout the day.
• Limit exposure to smoke, dust, and air‑conditioning drafts.
• Take regular breaks during prolonged visual tasks.
• Adopt a diligent lid‑hygiene routine, especially if you have blepharitis or rosacea.
• Ask your healthcare provider about alternatives if you need to start a medication known to cause dry eye.

Complications

If left untreated, xeritis can lead to serious ocular issues:

• Corneal epithelial breakdown – ulceration or erosions that cause pain and risk infection.
• Infectious keratitis – bacterial or fungal infection of the cornea.
• Scarring and neovascularization – can permanently impair vision.
• Reduced visual acuity – chronic inflammation interferes with clear optical surface.
• Impact on mental health – chronic discomfort may contribute to anxiety or depression.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Dry eye.” Updated 2023. https://www.mayoclinic.org.
2. World Health Organization. “Global prevalence of dry eye disease.” 2022. https://www.who.int.
3. American Academy of Ophthalmology. “Effect of omega‑3 supplementation on dry eye disease.” 2021. https://www.aao.org.
4. National Eye Institute (NEI). “Dry Eye.” 2024. https://nei.nih.gov.
5. Cleveland Clinic. “Dry Eye Syndrome.” 2023. https://my.clevelandclinic.org.

```